Pensionfund Sabic Makes New Investment in Eli Lilly and Company

Got story updates? Submit your updates here. ›

Pensionfund Sabic, an institutional investor, acquired a new stake in shares of Eli Lilly and Company (NYSE:LLY) in the 4th quarter, according to a disclosure with the Securities and Exchange Commission (SEC). The fund acquired 1,700 shares of the pharmaceutical company's stock, valued at approximately $1,827,000.

Why it matters

This investment by Pensionfund Sabic in Eli Lilly and Company, a major pharmaceutical company, reflects the fund's confidence in the company's growth potential and future prospects. Eli Lilly is a leading global pharmaceutical company known for its innovative medicines and therapies.

The details

According to the SEC filing, Pensionfund Sabic acquired the 1,700 shares of Eli Lilly and Company in the fourth quarter. The shares were valued at approximately $1,827,000. The investment is part of Pensionfund Sabic's portfolio diversification strategy, as the fund seeks to invest in promising companies across various sectors.

• Pensionfund Sabic acquired the 1,700 shares of Eli Lilly and Company in the 4th quarter of 2026.